GlobalData on MSN1d
FDA delays priority review of Neurotech’s eye cell therapy implantThe US regulatory agency has pushed the PDUFA date by three months to 18 March 2025 to “allow for more time to review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback